Not yet recruiting
Metapneumovirus infection
Not yet recruitingStudy on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
Investigational
Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
Investigational
- Disease:Metapneumovirus infection
- Substances:IVX-121Human metapneumovirus, virus-like protein
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:IVX-121
- Sponsor:AstraZeneca AB
